An ongoing series to help providers set the foundations of a patient's care.
FDA Approves Doravirine (Pifeltro) and New FDC With TDF/3TC (Delstrigo) in the U.S.
More People With HIV Virally Suppressed on Doravirine Than Darunavir at 96 Weeks, Study Shows
Latest DHHS Guidelines for Initial HIV Therapy Now Include 5 Choices -- but Really 2 Are Best
Who Tends to Gain Weight With HIV Treatment?
The field of hepatitis C disease management is in the midst of dramatic change. This series provides overviews, research updates, and more.
Hepatitis C Treatment Slashes Risk of Cancer and Improves Life Expectancy, Study Finds
Which Hepatitis C Treatment to Start
New Professional Resources for Providers to Address HIV/HCV Coinfection
Prison Health Is Public Health: The Case for Testing and Treating Hepatitis C in Prisons
This Week in HIV Research: From PrEP to Treatment, There's Always More to Learn
Overdoses and Smoking Are Taking the Lives of People With HIV Who Have Been Cured of Hepatitis C
Large French Study Examines Neuropsychiatric Side Effects With Integrase Inhibitors
Long-Acting HIV Treatment Is Coming. Our Health Care System Needs to Prepare
This Week in HIV Research: HIV Is Not an Obstacle
PrEP Use Is Correlated With an Increase in STIs, JAMA Study Finds
Depression Linked to Cognitive Dysfunction in HIV-Positive Women
Opioid Epidemic Is Fueling HIV Cluster Outbreaks -- Here's How CDC Is Responding
This Week in HIV Research: Fentanyl Smooths the Path for HIV
Researchers Crave More Data on HIV Care Continuum Programs for Recently Incarcerated People
New State-Level Maps from HepVu Show Impact of Hepatitis C Epidemic Across the U.S.
This Week in HIV Research: Additional Nuance on Pregnancy and Antiretrovirals
Native Americans Have HIV Treatment Adherence Rates on Par With Other Groups
'Female Condom' Gets a Genderless Rebrand From FDA
Virginia Governor Northam's Blackface Med School Antics Are the Reason Black Doctors Matter
Chlamydia and Gonorrhea Responsible for 10% of New HIV Infections Among MSM, According to New Study
For Our Stable HIV Patients, Why Are We Still Sending All These Lab Tests So Often?
Six Things Providers Should Know About HIV-Associated Neurocognitive Disorders
This Week in HIV Research: Check Your Frailty
This Week in HIV Research: The Power of 10,000 Steps
New Professional Resources for Providers to Address HIV/HCV Coinfection
© 2019 Remedy Health Media, LLC. All Rights Reserved
TheBodyPRO: About TheBodyPRO | Contact TheBodyPRO | Content Policy | Advertise With Us
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
TheBodyPRO is a service of Remedy Health Media, 461 Fifth Avenue, 14th Floor, New York, NY 10017. TheBodyPRO and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of TheBodyPRO's homepage, topic pages, page designs and HTML code. General Disclaimer: TheBodyPRO is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBodyPRO should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
